Iqbal Azad
Iqbal Azad publishes mostly in Organic Chemistry, Computational Theory and Mathematics and Molecular Biology, on topics such as Synthesis and biological activity, Computational Drug Discovery Methods and Synthesis and Characterization of Heterocyclic Compounds.
- World rank
- #1,290,693 of 7,710,434 ranked researchers
- Rank in India
- #19,492 of 280,097
- Works
- 52
- Citations
- 1.3k
- Citations per work
- 24.4
What does Iqbal Azad research?
Iqbal Azad's work is mostly in Chemistry (47%), Computer Science (12%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences3159.0%
- Chemistry2446.8%
- Computer Science612.2%
- Everything else1121.8%
- Life Sciences712.8%
- Health Sciences36.4%
- Medicine24.5%
- Health Professions11.9%
- 1Organic Chemistry47% of their works
- 2Computational Theory and Mathematics12% of their works
- 3Molecular Biology11% of their works
- 4Oncology4% of their works
- 5Pharmacology2% of their works
- 6General Health Professions2% of their works
Research topics
- Synthesis and biological activity
- Computational Drug Discovery Methods
- Synthesis and Characterization of Heterocyclic Compounds
- Multicomponent Synthesis of Heterocycles
- Metal complexes synthesis and properties
- Cancer therapeutics and mechanisms
- Click Chemistry and Applications
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Iqbal Azad's research?
The keywords of their largest research topics: Medicinal Chemistry, Anticancer Agents, Heterocyclic Compounds, Molecular Docking, Tubulin Inhibitors, Drug Discovery, Drug Target Identification and Virtual Screening.
- Phenothiazines
- Copper-Catalyzed Cycloaddition
- Topoisomerases
- Platinum-Based Drugs
- Green Chemistry
- Triazines
- Synthesis
- Virtual Screening
- Drug Discovery
- Molecular Docking
- Anticancer Agents
- Medicinal Chemistry
- Heterocyclic Compounds
- Tubulin Inhibitors
- Drug Target Identification
- Antimicrobial
- Biological Evaluation
- Cisplatin Resistance
- Multicomponent Reactions
- DNA
- Click Chemistry
- Biological Activities
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Medicinal Chemistry482 topics
- Anticancer Agents352 topics
- Heterocyclic Compounds291 topic
- Molecular Docking292 topics
- Tubulin Inhibitors291 topic
- Drug Discovery203 topics
- Drug Target Identification191 topic
- Virtual Screening191 topic
- Antimicrobial132 topics
- Synthesis132 topics
- Biological Evaluation101 topic
- Triazines101 topic
- Cisplatin Resistance61 topic
- Green Chemistry61 topic
- Multicomponent Reactions61 topic
- Platinum-Based Drugs61 topic
- DNA51 topic
- Topoisomerases51 topic
- Click Chemistry41 topic
- Copper-Catalyzed Cycloaddition41 topic
- Biological Activities31 topic
- Phenothiazines31 topic
Where does Iqbal Azad work?
Iqbal Azad's main affiliation in the publication record is Integral University, India.
How many publications and citations does Iqbal Azad have?
OpenAlex counts 52 works and 1,267 citations for Iqbal Azad, an h-index of 18, ranking #1,290,693 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Iqbal Azad. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.